Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
16.03
-0.17 (-1.05%)
At close: Oct 30, 2026, 4:00 PM EDT
15.98
-0.05 (-0.32%)
After-hours: Oct 30, 2026, 7:56 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $12.82 billion as of October 30, 2026. It is the 1,729th most valuable company in the world and the 646th biggest in the United States. Its market cap has decreased by 7.71% in one year.
Market Cap
12.82B
Enterprise Value
12.15B
1-Year Change
-7.71%
Global Rank
Country Rank
#646 United States
Category
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $12.82B, an increase of 10,672.79%. That is a compound annual growth rate of 49.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 12.72B | -2.34% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascendis Pharma | 16.43B |
| Halozyme Therapeutics | 14.84B |
| BridgeBio Pharma | 14.46B |
| Jazz Pharmaceuticals | 13.91B |
| Bio-Techne | 11.40B |
| BioMarin Pharmaceutical | 11.28B |
| Kymera Therapeutics | 10.68B |
| Madrigal Pharmaceuticals | 9.92B |